Fingerprint
Dive into the research topics where Erica Brivio is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials
Peccatori, N., Brivio, E., Lissat, A., Bautista Sirvent, F., Salzer, E., Biondi, A., Fazio, G., Rizzari, C., Tasian, S. K. & Zwaan, C. M., Oct 2025, In: Cancers. 17, 20, 3322.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile4 Downloads (Pure) -
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Pearson, A. D. J., Rossig, C., Mackall, C. L., Shah, N. N., Baruchel, A., Daems, S., Anderson, J., Biondi, A., Bird, N., Bodmer, N., Brivio, E., Buechner, J., Calkoen, F. G., Cooper, T., de Rojas, T., Fox, E., Gardner, R., Ghorashian, S., Heenen, D. & Ifversen, M. & 24 others, , Apr 2025, In: The Lancet Oncology. 26, 4, p. e214-e224Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile7 Citations (Web of Science)6 Downloads (Pure) -
The Role of Candidate Polymorphisms in Drug Transporter Genes on High-Dose Methotrexate in the Consolidation Phase of the AIEOP-BFM ALL 2009 Protocol
Braidotti, S., Zudeh, G., Franca, R., Kiren, V., Colombini, A., Bettini, L. R., Brivio, E., Locatelli, F., Vinti, L., Bertorello, N., Fagioli, F., Silvestri, D., Valsecchi, M. G., Decorti, G., Stocco, G. & Rabusin, M., Feb 2025, In: Clinical and Translational Science. 18, 2, e70136.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Citations (Scopus)34 Downloads (Pure) -
Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial
Pennesi, E., Brivio, E., Ammerlaan, A. C. J., Jiang, Y., van der Velden, V. H. J., Beverloo, H. B., Sleight, B., Locatelli, F., Brethon, B., Rossig, C., Engstler, G., Nilsson, A., Bruno, B., Petit, A., Bielorai, B., Rizzari, C., Rialland, F., Rubio-San-Simón, A., Bautista Sirvent, F. J. & Diaz-De-Heredia, C. & 2 others, , Oct 2024, In: Haematologica. 109, 10, p. 3157-3166 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile18 Citations (Scopus)99 Downloads (Pure) -
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059
Wu, J.-H., Pennesi, E., Bautista, F., Garrett, M., Fukuhara, K., Brivio, E., Ammerlaan, A. C. J., Locatelli, F., van der Sluis, I. M., Rossig, C., Chen-Santel, C., Bielorai, B., Petit, A., Stary, J., Diaz-de-Heredia, C., Rives, S., O'Marcaigh, A., Rizzari, C., Engstler, G. & Nysom, K. & 10 others, , Jul 2024, In: Clinical Pharmacokinetics. 63, 7, p. 981-997 17 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)26 Downloads (Pure)